Treatment Considerations for ASCVD & LDL-C Management

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Treatment Considerations for ASCVD & LDL-C Management

Playback speed

10 seconds

Update on Lipids: Current Options for Lowering LDL to Reduce CV Risk

By Jefferson Health FEATURING Adam Cohen

4,097 views

April 24, 2023

Comments 6

Non-Statin Therapies for Elevated LDL-C: The Role of Inclisiran (and…

Canadian Collaborative Research Network

J. Genest

871 views

Familial Hypercholesterolemia: From Diagnosis to Treatment

Scripps Health

P. Duell

350 views

HID 2023 Insights: LDL-C - How Low Can We Go Safely?

Seth Martin

2.8K views

Treatment of Lipids in 2023: Where Are We Now and Where Are We Going?

Houston Methodist DeBakey Heart and Vascular Center

C. Ballantyne

4.2K views

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

AHA 2022 Conference Coverage

K. Ray

10.8K views

ENDO 2022: Targeting PCSK9 for LDL-C Reduction

Connie Newman

1.8K views

Lipid Lowering Therapies: Where Did We Start, Where We Are Now and W…

The Texas Heart Institute

S. Virani

5.5K views

Lipids Update: Current Guidelines for Lipid Management

Scripps Health

S. R. Mehta

10.7K views

Lipid Management & Low Carb Diets

Metabolic Health Summit

B. Scher

3.8K views

Non-Statin Pharmacotherapies for Risk Reduction

Scripps Health

M. Wilkinson

3.4K views

Lipids Update: Overview of Current Guidelines for Lipid Management

Scripps Health

D. Cork

1.7K views